Dr Robert Azizi, MD - Medicare Diagnostic Radiology in Bell Gardens, CA

Dr Robert Azizi, MD is a medicare enrolled "Radiology - Vascular & Interventional Radiology" physician in Bell Gardens, California. He went to University Of Southern California Keck School Of Medicine and graduated in 2008 and has 16 years of diverse experience with area of expertise as Diagnostic Radiology. His current practice location is 8218 Garfield Ave, Bell Gardens, California. You can reach out to his office (for appointments etc.) via phone at (833) 736-3988.

Dr Robert Azizi is licensed to practice in California (license number A115565) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1316101298.

Contact Information

Dr Robert Azizi, MD
8218 Garfield Ave,
Bell Gardens, CA 90201-6212
(833) 736-3988
Not Available



Physician's Profile

Full NameDr Robert Azizi
GenderMale
SpecialityDiagnostic Radiology
Experience16 Years
Location8218 Garfield Ave, Bell Gardens, California
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Robert Azizi attended and graduated from University Of Southern California Keck School Of Medicine in 2008
  NPI Data:
  • NPI Number: 1316101298
  • Provider Enumeration Date: 07/10/2008
  • Last Update Date: 05/03/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 3779872981
  • Enrollment ID: I20160511001425

Medical Identifiers

Medical identifiers for Dr Robert Azizi such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1316101298NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2085R0204XRadiology - Vascular & Interventional Radiology A115565 (California)Primary
2085R0202XRadiology - Diagnostic Radiology A115565 (California)Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Robert Azizi allows following entities to bill medicare on his behalf.
Entity NameRenaissance Imaging Medical Associates Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1487608931
PECOS PAC ID: 7315841756
Enrollment ID: O20031126000257

News Archive

Study reports a drop in Medicare reimbursement rates for orthopedic trauma surgery

The amount Medicare reimburses for orthopedic trauma surgery has fallen by nearly one-third over the past two decades, reports a study in the Journal of Orthopaedic Trauma.

Researchers receive £2 million to study how to improve asthma in African children

Researchers from Queen Mary University of London have been awarded £2 million to study how to improve asthma in African children.

New brain-to-computer chip technology revolutionizes neurological therapy

By stimulating certain areas of the brain, scientists can alleviate the effects of disorders such as depression or Parkinson's disease. That's the good news. But because controlling that stimulation currently lacks precision, over-stimulation is a serious concern - losing some of its therapeutic benefits for the patient over time.

FASEB urges LHHS Appropriations Subcommittee to increase NIH budget to $37 billion

FASEB President William T. Talman, M.D. today sent a letter to the House Labor, Health and Human Services, Education (LHHS) Appropriations Subcommittee urging that the budget for the National Institutes of Health (NIH) be $37 billion in fiscal year (FY) 2011. "The opportunities for continued progress have never been greater, but we need adequate resources to ensure that progress is not curtailed," Talman stated.

FDA approves new nasal spray for adults who overproduce urine at night

The U.S. Food and Drug Administration today approved Noctiva (desmopressin acetate) nasal spray for adults who awaken at least two times per night to urinate due to a condition known as nocturnal polyuria (overproduction of urine during the night).

Read more Medical News

› Verified 2 days ago

Entity NameVascular Associates Of Southern California, Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1689835563
PECOS PAC ID: 9335285543
Enrollment ID: O20091001000241

News Archive

Study reports a drop in Medicare reimbursement rates for orthopedic trauma surgery

The amount Medicare reimburses for orthopedic trauma surgery has fallen by nearly one-third over the past two decades, reports a study in the Journal of Orthopaedic Trauma.

Researchers receive £2 million to study how to improve asthma in African children

Researchers from Queen Mary University of London have been awarded £2 million to study how to improve asthma in African children.

New brain-to-computer chip technology revolutionizes neurological therapy

By stimulating certain areas of the brain, scientists can alleviate the effects of disorders such as depression or Parkinson's disease. That's the good news. But because controlling that stimulation currently lacks precision, over-stimulation is a serious concern - losing some of its therapeutic benefits for the patient over time.

FASEB urges LHHS Appropriations Subcommittee to increase NIH budget to $37 billion

FASEB President William T. Talman, M.D. today sent a letter to the House Labor, Health and Human Services, Education (LHHS) Appropriations Subcommittee urging that the budget for the National Institutes of Health (NIH) be $37 billion in fiscal year (FY) 2011. "The opportunities for continued progress have never been greater, but we need adequate resources to ensure that progress is not curtailed," Talman stated.

FDA approves new nasal spray for adults who overproduce urine at night

The U.S. Food and Drug Administration today approved Noctiva (desmopressin acetate) nasal spray for adults who awaken at least two times per night to urinate due to a condition known as nocturnal polyuria (overproduction of urine during the night).

Read more Medical News

› Verified 2 days ago

Entity NameValley Village Vein Clinic Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1811201643
PECOS PAC ID: 0143409862
Enrollment ID: O20110127000534

News Archive

Study reports a drop in Medicare reimbursement rates for orthopedic trauma surgery

The amount Medicare reimburses for orthopedic trauma surgery has fallen by nearly one-third over the past two decades, reports a study in the Journal of Orthopaedic Trauma.

Researchers receive £2 million to study how to improve asthma in African children

Researchers from Queen Mary University of London have been awarded £2 million to study how to improve asthma in African children.

New brain-to-computer chip technology revolutionizes neurological therapy

By stimulating certain areas of the brain, scientists can alleviate the effects of disorders such as depression or Parkinson's disease. That's the good news. But because controlling that stimulation currently lacks precision, over-stimulation is a serious concern - losing some of its therapeutic benefits for the patient over time.

FASEB urges LHHS Appropriations Subcommittee to increase NIH budget to $37 billion

FASEB President William T. Talman, M.D. today sent a letter to the House Labor, Health and Human Services, Education (LHHS) Appropriations Subcommittee urging that the budget for the National Institutes of Health (NIH) be $37 billion in fiscal year (FY) 2011. "The opportunities for continued progress have never been greater, but we need adequate resources to ensure that progress is not curtailed," Talman stated.

FDA approves new nasal spray for adults who overproduce urine at night

The U.S. Food and Drug Administration today approved Noctiva (desmopressin acetate) nasal spray for adults who awaken at least two times per night to urinate due to a condition known as nocturnal polyuria (overproduction of urine during the night).

Read more Medical News

› Verified 2 days ago

Entity NameWest Hollywood Vein Clinic Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1881960920
PECOS PAC ID: 0446413090
Enrollment ID: O20120518000496

News Archive

Study reports a drop in Medicare reimbursement rates for orthopedic trauma surgery

The amount Medicare reimburses for orthopedic trauma surgery has fallen by nearly one-third over the past two decades, reports a study in the Journal of Orthopaedic Trauma.

Researchers receive £2 million to study how to improve asthma in African children

Researchers from Queen Mary University of London have been awarded £2 million to study how to improve asthma in African children.

New brain-to-computer chip technology revolutionizes neurological therapy

By stimulating certain areas of the brain, scientists can alleviate the effects of disorders such as depression or Parkinson's disease. That's the good news. But because controlling that stimulation currently lacks precision, over-stimulation is a serious concern - losing some of its therapeutic benefits for the patient over time.

FASEB urges LHHS Appropriations Subcommittee to increase NIH budget to $37 billion

FASEB President William T. Talman, M.D. today sent a letter to the House Labor, Health and Human Services, Education (LHHS) Appropriations Subcommittee urging that the budget for the National Institutes of Health (NIH) be $37 billion in fiscal year (FY) 2011. "The opportunities for continued progress have never been greater, but we need adequate resources to ensure that progress is not curtailed," Talman stated.

FDA approves new nasal spray for adults who overproduce urine at night

The U.S. Food and Drug Administration today approved Noctiva (desmopressin acetate) nasal spray for adults who awaken at least two times per night to urinate due to a condition known as nocturnal polyuria (overproduction of urine during the night).

Read more Medical News

› Verified 2 days ago

Entity NameMid Valley Vascular Center, Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1790187169
PECOS PAC ID: 5395967186
Enrollment ID: O20141111001439

News Archive

Study reports a drop in Medicare reimbursement rates for orthopedic trauma surgery

The amount Medicare reimburses for orthopedic trauma surgery has fallen by nearly one-third over the past two decades, reports a study in the Journal of Orthopaedic Trauma.

Researchers receive £2 million to study how to improve asthma in African children

Researchers from Queen Mary University of London have been awarded £2 million to study how to improve asthma in African children.

New brain-to-computer chip technology revolutionizes neurological therapy

By stimulating certain areas of the brain, scientists can alleviate the effects of disorders such as depression or Parkinson's disease. That's the good news. But because controlling that stimulation currently lacks precision, over-stimulation is a serious concern - losing some of its therapeutic benefits for the patient over time.

FASEB urges LHHS Appropriations Subcommittee to increase NIH budget to $37 billion

FASEB President William T. Talman, M.D. today sent a letter to the House Labor, Health and Human Services, Education (LHHS) Appropriations Subcommittee urging that the budget for the National Institutes of Health (NIH) be $37 billion in fiscal year (FY) 2011. "The opportunities for continued progress have never been greater, but we need adequate resources to ensure that progress is not curtailed," Talman stated.

FDA approves new nasal spray for adults who overproduce urine at night

The U.S. Food and Drug Administration today approved Noctiva (desmopressin acetate) nasal spray for adults who awaken at least two times per night to urinate due to a condition known as nocturnal polyuria (overproduction of urine during the night).

Read more Medical News

› Verified 2 days ago

Entity NameGlendale Vein Clinic Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1245658988
PECOS PAC ID: 6608191762
Enrollment ID: O20150212000039

News Archive

Study reports a drop in Medicare reimbursement rates for orthopedic trauma surgery

The amount Medicare reimburses for orthopedic trauma surgery has fallen by nearly one-third over the past two decades, reports a study in the Journal of Orthopaedic Trauma.

Researchers receive £2 million to study how to improve asthma in African children

Researchers from Queen Mary University of London have been awarded £2 million to study how to improve asthma in African children.

New brain-to-computer chip technology revolutionizes neurological therapy

By stimulating certain areas of the brain, scientists can alleviate the effects of disorders such as depression or Parkinson's disease. That's the good news. But because controlling that stimulation currently lacks precision, over-stimulation is a serious concern - losing some of its therapeutic benefits for the patient over time.

FASEB urges LHHS Appropriations Subcommittee to increase NIH budget to $37 billion

FASEB President William T. Talman, M.D. today sent a letter to the House Labor, Health and Human Services, Education (LHHS) Appropriations Subcommittee urging that the budget for the National Institutes of Health (NIH) be $37 billion in fiscal year (FY) 2011. "The opportunities for continued progress have never been greater, but we need adequate resources to ensure that progress is not curtailed," Talman stated.

FDA approves new nasal spray for adults who overproduce urine at night

The U.S. Food and Drug Administration today approved Noctiva (desmopressin acetate) nasal spray for adults who awaken at least two times per night to urinate due to a condition known as nocturnal polyuria (overproduction of urine during the night).

Read more Medical News

› Verified 2 days ago

Entity NameUsa Vascular Centers Of Los Angeles Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1679951362
PECOS PAC ID: 0345558128
Enrollment ID: O20151001000391

News Archive

Study reports a drop in Medicare reimbursement rates for orthopedic trauma surgery

The amount Medicare reimburses for orthopedic trauma surgery has fallen by nearly one-third over the past two decades, reports a study in the Journal of Orthopaedic Trauma.

Researchers receive £2 million to study how to improve asthma in African children

Researchers from Queen Mary University of London have been awarded £2 million to study how to improve asthma in African children.

New brain-to-computer chip technology revolutionizes neurological therapy

By stimulating certain areas of the brain, scientists can alleviate the effects of disorders such as depression or Parkinson's disease. That's the good news. But because controlling that stimulation currently lacks precision, over-stimulation is a serious concern - losing some of its therapeutic benefits for the patient over time.

FASEB urges LHHS Appropriations Subcommittee to increase NIH budget to $37 billion

FASEB President William T. Talman, M.D. today sent a letter to the House Labor, Health and Human Services, Education (LHHS) Appropriations Subcommittee urging that the budget for the National Institutes of Health (NIH) be $37 billion in fiscal year (FY) 2011. "The opportunities for continued progress have never been greater, but we need adequate resources to ensure that progress is not curtailed," Talman stated.

FDA approves new nasal spray for adults who overproduce urine at night

The U.S. Food and Drug Administration today approved Noctiva (desmopressin acetate) nasal spray for adults who awaken at least two times per night to urinate due to a condition known as nocturnal polyuria (overproduction of urine during the night).

Read more Medical News

› Verified 2 days ago

Entity NameVascular Interventional Partners Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1306218011
PECOS PAC ID: 7012213424
Enrollment ID: O20160310002688

News Archive

Study reports a drop in Medicare reimbursement rates for orthopedic trauma surgery

The amount Medicare reimburses for orthopedic trauma surgery has fallen by nearly one-third over the past two decades, reports a study in the Journal of Orthopaedic Trauma.

Researchers receive £2 million to study how to improve asthma in African children

Researchers from Queen Mary University of London have been awarded £2 million to study how to improve asthma in African children.

New brain-to-computer chip technology revolutionizes neurological therapy

By stimulating certain areas of the brain, scientists can alleviate the effects of disorders such as depression or Parkinson's disease. That's the good news. But because controlling that stimulation currently lacks precision, over-stimulation is a serious concern - losing some of its therapeutic benefits for the patient over time.

FASEB urges LHHS Appropriations Subcommittee to increase NIH budget to $37 billion

FASEB President William T. Talman, M.D. today sent a letter to the House Labor, Health and Human Services, Education (LHHS) Appropriations Subcommittee urging that the budget for the National Institutes of Health (NIH) be $37 billion in fiscal year (FY) 2011. "The opportunities for continued progress have never been greater, but we need adequate resources to ensure that progress is not curtailed," Talman stated.

FDA approves new nasal spray for adults who overproduce urine at night

The U.S. Food and Drug Administration today approved Noctiva (desmopressin acetate) nasal spray for adults who awaken at least two times per night to urinate due to a condition known as nocturnal polyuria (overproduction of urine during the night).

Read more Medical News

› Verified 2 days ago

Entity NameValley Vascular Partners, Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1407393754
PECOS PAC ID: 0941583611
Enrollment ID: O20170203002353

News Archive

Study reports a drop in Medicare reimbursement rates for orthopedic trauma surgery

The amount Medicare reimburses for orthopedic trauma surgery has fallen by nearly one-third over the past two decades, reports a study in the Journal of Orthopaedic Trauma.

Researchers receive £2 million to study how to improve asthma in African children

Researchers from Queen Mary University of London have been awarded £2 million to study how to improve asthma in African children.

New brain-to-computer chip technology revolutionizes neurological therapy

By stimulating certain areas of the brain, scientists can alleviate the effects of disorders such as depression or Parkinson's disease. That's the good news. But because controlling that stimulation currently lacks precision, over-stimulation is a serious concern - losing some of its therapeutic benefits for the patient over time.

FASEB urges LHHS Appropriations Subcommittee to increase NIH budget to $37 billion

FASEB President William T. Talman, M.D. today sent a letter to the House Labor, Health and Human Services, Education (LHHS) Appropriations Subcommittee urging that the budget for the National Institutes of Health (NIH) be $37 billion in fiscal year (FY) 2011. "The opportunities for continued progress have never been greater, but we need adequate resources to ensure that progress is not curtailed," Talman stated.

FDA approves new nasal spray for adults who overproduce urine at night

The U.S. Food and Drug Administration today approved Noctiva (desmopressin acetate) nasal spray for adults who awaken at least two times per night to urinate due to a condition known as nocturnal polyuria (overproduction of urine during the night).

Read more Medical News

› Verified 2 days ago

Entity NameVascular Intervention Specialists Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1063959310
PECOS PAC ID: 0547543753
Enrollment ID: O20170214002134

News Archive

Study reports a drop in Medicare reimbursement rates for orthopedic trauma surgery

The amount Medicare reimburses for orthopedic trauma surgery has fallen by nearly one-third over the past two decades, reports a study in the Journal of Orthopaedic Trauma.

Researchers receive £2 million to study how to improve asthma in African children

Researchers from Queen Mary University of London have been awarded £2 million to study how to improve asthma in African children.

New brain-to-computer chip technology revolutionizes neurological therapy

By stimulating certain areas of the brain, scientists can alleviate the effects of disorders such as depression or Parkinson's disease. That's the good news. But because controlling that stimulation currently lacks precision, over-stimulation is a serious concern - losing some of its therapeutic benefits for the patient over time.

FASEB urges LHHS Appropriations Subcommittee to increase NIH budget to $37 billion

FASEB President William T. Talman, M.D. today sent a letter to the House Labor, Health and Human Services, Education (LHHS) Appropriations Subcommittee urging that the budget for the National Institutes of Health (NIH) be $37 billion in fiscal year (FY) 2011. "The opportunities for continued progress have never been greater, but we need adequate resources to ensure that progress is not curtailed," Talman stated.

FDA approves new nasal spray for adults who overproduce urine at night

The U.S. Food and Drug Administration today approved Noctiva (desmopressin acetate) nasal spray for adults who awaken at least two times per night to urinate due to a condition known as nocturnal polyuria (overproduction of urine during the night).

Read more Medical News

› Verified 2 days ago

Entity NameVascular Interventions, Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1003402884
PECOS PAC ID: 9537576186
Enrollment ID: O20210325002046

News Archive

Study reports a drop in Medicare reimbursement rates for orthopedic trauma surgery

The amount Medicare reimburses for orthopedic trauma surgery has fallen by nearly one-third over the past two decades, reports a study in the Journal of Orthopaedic Trauma.

Researchers receive £2 million to study how to improve asthma in African children

Researchers from Queen Mary University of London have been awarded £2 million to study how to improve asthma in African children.

New brain-to-computer chip technology revolutionizes neurological therapy

By stimulating certain areas of the brain, scientists can alleviate the effects of disorders such as depression or Parkinson's disease. That's the good news. But because controlling that stimulation currently lacks precision, over-stimulation is a serious concern - losing some of its therapeutic benefits for the patient over time.

FASEB urges LHHS Appropriations Subcommittee to increase NIH budget to $37 billion

FASEB President William T. Talman, M.D. today sent a letter to the House Labor, Health and Human Services, Education (LHHS) Appropriations Subcommittee urging that the budget for the National Institutes of Health (NIH) be $37 billion in fiscal year (FY) 2011. "The opportunities for continued progress have never been greater, but we need adequate resources to ensure that progress is not curtailed," Talman stated.

FDA approves new nasal spray for adults who overproduce urine at night

The U.S. Food and Drug Administration today approved Noctiva (desmopressin acetate) nasal spray for adults who awaken at least two times per night to urinate due to a condition known as nocturnal polyuria (overproduction of urine during the night).

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Robert Azizi is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Robert Azizi, MD
8218 Garfield Ave,
Bell Gardens, CA 90201-6212

Ph: (833) 736-3988
Dr Robert Azizi, MD
8218 Garfield Ave,
Bell Gardens, CA 90201-6212

Ph: (833) 736-3988

News Archive

Study reports a drop in Medicare reimbursement rates for orthopedic trauma surgery

The amount Medicare reimburses for orthopedic trauma surgery has fallen by nearly one-third over the past two decades, reports a study in the Journal of Orthopaedic Trauma.

Researchers receive £2 million to study how to improve asthma in African children

Researchers from Queen Mary University of London have been awarded £2 million to study how to improve asthma in African children.

New brain-to-computer chip technology revolutionizes neurological therapy

By stimulating certain areas of the brain, scientists can alleviate the effects of disorders such as depression or Parkinson's disease. That's the good news. But because controlling that stimulation currently lacks precision, over-stimulation is a serious concern - losing some of its therapeutic benefits for the patient over time.

FASEB urges LHHS Appropriations Subcommittee to increase NIH budget to $37 billion

FASEB President William T. Talman, M.D. today sent a letter to the House Labor, Health and Human Services, Education (LHHS) Appropriations Subcommittee urging that the budget for the National Institutes of Health (NIH) be $37 billion in fiscal year (FY) 2011. "The opportunities for continued progress have never been greater, but we need adequate resources to ensure that progress is not curtailed," Talman stated.

FDA approves new nasal spray for adults who overproduce urine at night

The U.S. Food and Drug Administration today approved Noctiva (desmopressin acetate) nasal spray for adults who awaken at least two times per night to urinate due to a condition known as nocturnal polyuria (overproduction of urine during the night).

Read more News

› Verified 2 days ago


Radiology Doctors in Bell Gardens, CA


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.